Skip to main content

Table 1 Descriptive characteristics of Epirus Health Study (EHS) participants

From: Awareness, knowledge and trust in the Greek authorities towards COVID-19 pandemic: results from the Epirus Health Study cohort

  Total sample (n = 667) Study sample (n = 563)
Age [years; mean (SD)] 48.7 (11.3) 48.7 (11.0)
Sex [n (%)]
 Women 399 (59.8) 337 (59.9)
Maximum level of education [n (%)]
 Junior high school 67 (10.1) 52 (9.3)
 High school 165 (24.8) 136 (24.2)
 University 264 (39.6) 228 (40.6)
 Post-graduate studies 170 (25.5) 146 (26.0)
Smoking status1 [n (%)]
 Non-smokers 297 (44.5) 247 (43.9)
 Former smokers 163 (24.4) 140 (24.9)
 Current smokers 207 (31.0) 176 (31.3)
Alcohol consumption [n (%)]
 Never 58 (8.7) 51 (9.1)
 Less than once/month 210 (31.5) 177 (31.4)
 1–3 times/month 110 (16.5) 94 (16.7)
 1–2 times/week 176 (26.4) 152 (27.0)
 At least 3 times/week 113 (16.9) 89 (15.8)
Moderate-intensity recreational PA [METs-hours/week, mean (SD)] 5.3 (11.0) 5.5 (11.5)
Vigorous-intensity recreational PA [METs-hours/week, mean (SD)] 5.4 (15.4) 4.9 (14.6)
Mediterranean diet assessment score [mean (SD)] 7.2 (1.8) 7.1 (1.8)
Pittsburgh sleep quality index [mean (SD)] 5.1 (2.6) 5.0 (2.4)
Body mass index2 [kg/m2; mean (SD)] 26.5 (4.7) 26.6 (4.7)
Body fat2 [%; mean (SD)] 28.4 (7.8) 28.4 (7.8)
Systolic blood pressure3 [mmHg; mean (SD)] 117.2 (15.1) 117.5 (15.1)
Diastolic blood pressure3 [mmHg; mean (SD)] 75.0 (9.9) 75.2 (9.9)
Total cholesterol4 [mg/dL; mean (SD)] 194.7 (34.1) 194.7 (34.0)
Low-density lipoprotein cholesterol4 [mg/dL; mean (SD)] 126.4 (33.6) 126.2 (33.5)
High-density lipoprotein cholesterol4 [mg/dL; mean (SD)] 54.3 (11.7) 54.2 (11.8)
Triglycerides4 [mg/dL; mean (SD)] 94.6 (57.9) 96.7 (59.7)
Glucose4 [mg/dL; mean (SD)] 85.5 (15.5) 85.6 (15.9)
  1. Abbreviations: METs, Metabolic equivalents of energy expenditure; PA, Physical activity; SD, Standard deviation
  2. 1Variable indicating smoking status was constructed as follows: non-smokers; participants who were lifelong non-smokers or have tasted smoking products once or twice, former smokers; participants who have quitted smoking, current smokers; participants who smoked occasionally or were active smokers
  3. 2Parameters from lipometry tests conducted in the context of EHS
  4. 3Parameters measured using blood pressure monitors in the context of EHS
  5. 4Parameters from blood tests conducted in the context of EHS